Fundc1 protects against doxorubicin-induced cardiomyocyte panoptosis through stabilizing mtdna via interaction with tufm

HIGHLIGHTS

• who: Yaguang Bi from the Human samples Human heart samples were obtained from patients who have undergone heart transplant surgery due to DCM or the doner heart failed with transplantation due to non-cardiac reasons (n=6/group, informed consent was obtained from all subjects), from the Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University (Guangzhou, China)The study was approved by the institutional ethics committee of Sun Yat-Sen Memorial Hospital. have published the research work: FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM, in the Journal: (JOURNAL) of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.